Jeremy Grantham's top holdings (April 2026) include Lam Research Corp. (LRCX), a key supplier of wafer fabrication equipment and services to the semiconductor industry.

Jeremy Grantham is a co-founder and the chief investment strategist of Grantham, Mayo, & van Otterloo (GMO), an investment management firm. His work at GMO focuses on long-term investment strategies and identifying significant market trends and asset mispricings.

Lam Research Corp. (LRCX)

Lam Research is a leading global supplier of innovative wafer fabrication equipment and services. These products are critical for manufacturing advanced integrated circuits found in modern electronic devices. The company maintains a market capitalization of $264.0 billion, and Jeremy Grantham's position in Lam Research is currently valued at $2.0 billion. Analysts tracking the stock have set a price target of $254.46, while a discounted cash flow analysis suggests a value of $50.4 per share.
Here's an overview of Jeremy Grantham's trades in Lam Research Corp.:

Microsoft Corporation (MSFT)

Microsoft Corporation is a multinational technology giant known for its wide array of software products, services, and hardware. Key offerings include the Windows operating system, Office productivity suite, Azure cloud services, and the Xbox gaming platform. With a vast market presence, Microsoft's market cap stands at $2.65 trillion. The current value of Jeremy Grantham's holding in the company is $1.95 billion. The discounted cash flow value for Microsoft is $342.67 per share, and analysts have established a price target of $573.92.
Here's an overview of Jeremy Grantham's trades in Microsoft Corporation:

Alphabet Inc (GOOGL)

Alphabet Inc. is the parent company of Google, focusing on internet-related services and products. Its core businesses encompass search, advertising, cloud computing through Google Cloud, and numerous other ventures and technologies. This holding in Jeremy Grantham's portfolio is currently worth $1.92 billion, while Alphabet boasts a market capitalization of $3.32 trillion. A discounted cash flow analysis for the company yields a value of $197.55 per share, and the analyst price target is $376.72.
Here's an overview of Jeremy Grantham's trades in Alphabet Inc:

Johnson & Johnson (JNJ)

Johnson & Johnson is a global healthcare company specializing in pharmaceutical, medical device, and consumer health products. The company develops and manufactures a broad range of items, serving patients and consumers across the world. With a market cap of $579.46 billion, Jeremy Grantham's position in Johnson & Johnson is currently valued at $1.73 billion. Analysts have set a price target of $231.63 for the company, and its discounted cash flow value is $274.85 per share.
Here's an overview of Jeremy Grantham's trades in Johnson & Johnson:

Apple Inc (AAPL)

Apple Inc. designs, manufactures, and markets consumer electronics, software, and online services. Its product lineup includes the iPhone, Mac, iPad, Apple Watch, and AirPods, alongside services like the App Store and Apple Music. Apple has a substantial global market presence, with its market cap standing at $3.66 trillion. Jeremy Grantham's position in the company is currently valued at $1.7 billion. The discounted cash flow for Apple is $148.18 per share, and analysts have established a price target of $314.99.
Here's an overview of Jeremy Grantham's trades in Apple Inc: